Synthesized 2-Substituted-3-Phenylthiazolidine-4-ones as Potent Antioxidants and Antidiabetic Agents
Purpose: To employ intramolecular cyclization of Schiff bases of pyrazole-4-carboxaldehydes to form thiazolidine-4-ones and determine the antioxidant and antidiabetic activity of the synthesized compounds.
Methods: The Schiff bases were obtained upon reaction between the electrophillic carbon atom of pyrazole-4-carboxaldehyde and the nucleophillic nitrogen atom of the amine. Preparation of thiazolidine-
4-one was preceded by attack of sulphur nucleophile of thioglycollic acid on imine carbon followed by intramolecular cyclization using acid catalyst. In vitro antioxidant activity was determined by 1, 1- diphenyl-2-picrylhydrazyl (DPPH) radical scavenging assay method using ascorbic acid as standard.
Evaluation of antidiabetic activity was carried out in streptazotocine-induced diabetes in Wister rats using rosiglitazone as reference drug. Blood glucose levels were estimated by GOD-POD kit. Serum biochemical parameters like total cholesterol, triglyceride, urea, creatinine and total protein level were
Results: Compounds 7a, 7b, 7c, 7e, 7j showed higher IC50 [Half maximal inhibitory concentration] values than the reference antioxidant, ascorbic acid. On the 21st day of treatment, there was significant fall and rise blood glucose level and body weight, respectively, compared to the anti-diabetic standard. There was decrease in serum cholesterol, triglyceride, creatinine and urea levels while high density lipoprotein (HDL) level and total protein levels increased after 21 days of treatment. Compared to rosiglitazone, compounds 7a, 7b, 7c, 7h, 7j showed stronger significant antidiabetic effect in hyperglycemic rats due, probably, to the presence of thiazolidine-4-one nucleus as well as parasubstitution on phenyl ring.
Conclusion: The 2-(3-Methyl-1H-pyrazol-4-yl)-3-phenylthiazolidin-4-ones possess potent antioxidant and antidiabetic activity but further studies are required to develop them for clinical use.
Keywords: Pyrazole-4-carboxaldehydes, Thiazolidine-4-one, Antioxidant, Anti diabetic
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.